· NY legislature · 2025-2026

Relates to capping cost sharing for antiviral COVID-19 therapeutics

Requires insurance companies, medical expense indemnity corporations, hospital service corporations, health service corporations and medical assistance programs to provide coverage for prescribed antiviral therapeutics approved by the food and drug administration for the treatment of COVID-19 at no cost to the patient.

Sponsor

Brad Hoylman-Sigal

Introduced

2025-03-27

Latest action

REFERRED TO INSURANCE